KMKagami Miyaji

Kagami Miyaji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kagami Miyaji has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • FOUR-DIMENSIONAL MAGNETIC RESONANCE IMAGING (4D-MRI) FLOW ENERGY LOSS: NEW INSIGHT INTO FONTAN CIRCULATION IN ADULT PATIENTS

    by Atsushi Kitagawa, Keiichi Itatani, Manabu Takanashi, Takashi Honda, Sumito Kimura, Kagami Miyaji, Masahiro Ishii

    • 1 March 2016
      • Vol. 69  (3) , 197-200

    [Emergency Surgery for Acute Pulmonary Embolism].

    by Kenjiro Sakaki, Masaki Nie, Akihiro Sasahara, Koki Nakashima, Kuniyoshi Ohara, Kagami Miyaji

    According to the current guidelines for acute pulmonary embolism in Japan, it is standard to perform surgical thrombectomy only after introducing percutaneous cardiopulmonary support (PCPS) for circulatory collapse. We experienced 2 cases of surgical thrombectomy without using PCPS. The 1st patient was a 49-year-old man. Computed tomography (CT) on admission revealed a thrombus in the main trunk of the pulmonary artery. He developed severe dyspnea and drop of consciousness after admission, and underwent emergency surgical thrombectomy. The 2nd patient was a 52-year-old man whose levels of consciousness and arterial oxygenation rapidly declined after admission. His CT revealed thrombi in the main trunk of the pulmonary artery, and he underwent emergency thrombectomy. Both patients had a history of diabetes and obesity. At our institute, we actively choose surgical thrombectomy for cases in which a thrombus is revealed in the main trunk of the pulmonary artery on CT and for cases in which abnormal symptoms and/or signs such as impaired consciousness and oxygenation develop.


  • Prolonged vortex formation during the ejection period in the left ventricle with low ejection fraction: a study by vector flow mapping

    by Nobuaki Fukuda, Keiichi Itatani, Koichi Kimura, Aya Ebihara, Kazuaki Negishi, Kansei Uno, Kagami Miyaji, Masahiko Kurabayashi, Katsu Takenaka

  • Useful surgical instruments for the resection of subaortic stenosis

    by Yuki Tanaka, Takashi Miyamoto, Kazutomo Minami, Kagami Miyaji


  • Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants

    by Miyuki Shibata, Keiichi Itatani, Norihiko Oka, Takeshi Yoshii, Yuki Nakamura, Tadashi Kitamura, Tetsuya Horai, Kagami Miyaji

    The modified Blalock-Taussig shunt (mBTS) is one of the most important palliative procedures in congenital heart surgery. However, in neonates and small infants, operative mortality and morbidity due to excessive pulmonary blood flow or shunt failure remains high. In this study, a small shunt graft (3.0-mm diameter) was estimated to determine the optimal shunt graft size of BTS as an initial palliation for ultimate biventricular circulation. Eighteen patients weighing an average 3.5 kg who underwent mBTS from July 2004 to January 2013 at our institute were reviewed. We divided the study cohort into two groups: group S (n = 10) included patients with 3.0-mm diameter shunt grafts, and group L (n = 8) included patients with 3.5-mm diameter shunt grafts. There were no hospital deaths or shunt occlusion in either group. One group L patient (12.5%) had cardiogenic shock due to excessive pulmonary blood flow. There were no differences in postoperative arterial oxygen saturation (SaO2) between the groups. There were no differences in body weight at intracardiac repair (ICR) between the groups. During the interstage to ICR, body weight gain was significantly greater in group S than in group L (P = 0.008). The small shunt graft (3.0-mm diameter) in BTS was safe, provided adequate pulmonary blood flow, and led to significant weight gain between mBTS and ICR for ultimate biventricular circulation in neonates and small infants with low body weight.


    • 1 May 2014
      • Vol. 67  (5) , 367-70

    [Outcomes of the surgical treatment of infectious endocarditis in a single institute for 13-years].

    by Yusuke Irisawa, Tadashi Kitamura, Keiichi Itatani, Takamichi Inoue, Hidenori Hayashi, Kenjirou Sakaki, Miyuki Shibata, Takahiro Tomoyasu, Norihiko Oka, Naoji Hanayama, et al.

    Recently, due to the progress in patient managements with antibiotics, the prognosis of the active phase infectious endocarditis (IE) has improved, but in some cases, urgent or emergent surgical treatment is inevitable because of the uncontrollable acute heart failure due to valve regurgitation, uncontrollable infection with circulatory collapse, or high embolization risk. We reviewed the outcomes of the 57 IE patients who underwent surgical treatment in our hospital from January, 2000 to April, 2012. Preoperative state including inflammatory responses, bacterial blood culture, antibiotic administration, and surgical procedures were examined. No statistical significances were detected in the mortalities between elective cases (n=43)and urgent or emergent cases (n=14). Totally, mortality was 5.3% including one case in prosthetic valve endocarditis, and was satisfactory.

  • Effect of Additional Preoperative Administration of the Neutrophil Elastase Inhibitor Sivelestat on Perioperative Inflammatory Response After Pediatric Heart Surgery With Cardiopulmonary Bypass

    by Satoshi Kohira, Norihiko Oka, Nobuyuki Inoue, Keiichi Itatani, Tadashi Kitamura, Tetsuya Horai, Hiroyuki Oshima, Keiichi Tojo, Shigenori Yoshitake, Kagami Miyaji

    Cardiopulmonary bypass (CPB) elicits a systemic inflammatory response. Our previous reports revealed that prophylactic sivelestat administration at CPB initiation suppresses the postoperative acute inflammatory response due to CPB in pediatric cardiac surgery. The purpose of this study was to compare the effects of sivelestat administration before CPB and at CPB initiation in patients undergoing pediatric open‐heart surgery. Twenty consecutive patients weighing 5–10 kg and undergoing ventricular septal defect closure with CPB were divided into pre‐CPB (n = 10) and control (n = 10) groups. Patients in the pre‐CPB group received a 24 h continuous intravenous infusion of 0.2 mg/kg/h sivelestat starting at the induction of anesthesia and an additional 0.1 mg/100 mL during CPB priming. Patients in the control group received a 24‐h continuous intravenous infusion of 0.2 mg/kg/h sivelestat starting at the commencement of CPB. Blood samples were tested. Clinical variables including blood loss, water balance, systemic vascular resistance index, and the ratio between partial pressure of oxygen and fraction of inspired oxygen (P/F ratio) were assessed. White blood cell count and neutrophil count as well as C‐reactive protein levels were significantly lower in the pre‐CPB group according to repeated two‐way analysis of variance, whereas platelet count was significantly higher. During CPB, mixed venous oxygen saturation remained significantly higher and lactate levels lower in the pre‐CPB group. Postoperative alanine aminotransferase and blood urea nitrogen levels were significantly lower in the pre‐CPB group than in the control group. The P/F ratio was significantly higher in the pre‐CPB group than in the control group. Fluid load requirement was significantly lower in the pre‐CPB group.Administration of sivelestat before CPB initiation is more effective than administration at initiation for the suppression of inflammatory responses due to CPB in pediatric open‐heart surgery, with this effect being confirmed by clinical evidence.


  • Experimental examination of the oxygenator gas flash

    by Keiichi Tojo, Masami Fujii, Haruna Kinoshita, Misaki Tamura, Hiroyuki Oshima, Akikazu Takeda, Satoshi Kohira, Kagami Miyaji

    長期間の経皮的心肺補助(percutaneous cardio pulmonary support:PCPS)では、人工肺中空糸内に貯留した水が人工肺のガス交換有効膜面積を減少させガス交換能低下を来す(ウエットラング状態)。このような場合、人工肺の吹送ガスを一時的に増加させ中空糸内の水を飛ばして(ガスフラッシュ)ガス交換能を改善させることがある。今回我々は、均質膜構造を持つ人工肺テルモ社製CAPIOX-LX、ニプロ社製BIOCUBE、多孔質膜にシリコンコーティングした泉工医科業社製EXCELUNG PRIMEについて実験用回路を作製してウエットラングを改善する方法について実験を行った。その結果、ウエットラング状態でのガス交換能の低下はBIOCUBE、エクセラン、CAPIOXの順で大きかった。ガスフラッシュによる有効膜面積は、EXCELUNG PRIME 25L/min、CAPIOX 10L/min、BIOCUBE 30L/min以上の吹送ガス流量にて改善できることが分かった。また、ガスフラッシュの時間は3種とも5秒で効果が得られた。PCPSにおいて人工肺を長時間連続して使用する場合、結露によるウエットラングを防ぐことは困難であるが、ガス交換能回復が見込めることが示唆された。